● Recruiting

Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

Condition: Cancer · Immune System or Toxicities Suspected · Sponsor: Institut Curie

PhaseNA

Planned participants300

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The study will evaluate the detection of tumor-antigen specific immune cells in cancer patients in whom the role of the immune system is suspected.

This description comes directly from the study's public registry record.

Talk to the study team

Cyrine EZZILI, PhD · 0033147111657 · cyrine.ezzili@curie.fr

Fouzia AZZOUZ · fouzia.azzouz@curie.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Institut Curie	Paris, France	Recruiting
Institut Curie	Saint-Cloud, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05354765